With effect from 15 February 2016 the businesses of Al Noor
Hospitals Group plc (“Al Noor”) and Mediclinic International Limited
(“Mediclinic”) were combined by way of a reverse takeover by Al Noor of
Mediclinic (“the Combination”). The Combination was effected by way of a
scheme of arrangement under the South African Companies Act under which
Mediclinic shareholders received 0.62500 new Al Noor shares for each
Mediclinic share held as at the scheme record date. The company name of Al
Noor will change to Mediclinic International plc on or about 15 February
2016 and the enlarged group will have a premium listing on the Main Market
of the London Stock Exchange (share code: ANH), as well as an inward
secondary listing on the Main Board of the Johannesburg Stock Exchange
(share code: MEI).
Please visit the website of
further Investor Relations information.